Lund SLE Research Group
1 – 10 of 60
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing (
- Contributions of de novo variants to systemic lupus erythematosus (
- 2020
- Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus (
- NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus (
- High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus (
- Peripheral Nervous System Disease in Systemic Lupus Erythematosus : Results From an International Inception Cohort Study (
- High Prevalence and Disease Correlation of Autoantibodies Against p40 Encoded by Long Interspersed Nuclear Elements in Systemic Lupus Erythematosus (
- Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus : A multi-center observational study (
- Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index (
- Neuropsychiatric events in systemic lupus erythematosus : A longitudinal analysis of outcomes in an international inception cohort using a multistate model approach (